Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedThe press release list now features Viatris’ U.S. FDA approval of RYZUMVI for presbyopia, while the earlier announcement that the FDA accepted its meloxicam application for acute pain is no longer displayed.SummaryDifference7%

- Check20 days agoChange DetectedThe press-release list adds Viatris’s October 8, 2026 announcement of an agreement to acquire Pacira BioSciences and its expansion in non-opioid pain therapies, while an older healthcare conference notice is no longer listed.SummaryDifference7%

- Check27 days agoChange DetectedThe release list adds Viatris’s October 5 announcement of its upcoming third-quarter 2026 results and its September 29 recognition by Forbes as a Best Employer. The May 5 first-quarter 2026 results release is no longer listed.SummaryDifference6%

- Check41 days agoChange DetectedA new press release announces WAKIX approval in Japan, signaling regulatory progress in a key market. The listing of the Chief Financial Officer transition has been removed from the press releases.SummaryDifference7%

- Check84 days agoChange DetectedTwo August 2026 press releases were added to the Viatris Newsroom: Q2 financial results and a quarterly dividend. Several earlier 2026 items were removed, including the May 1 release on data presentations and the April 13 release about the May 7 financial results.SummaryDifference7%

- Check91 days agoChange DetectedA new press release entry for July 29, 2026 announcing FDA approval of Gwyn Lo contraceptive patch was added. The April 10, 2026 data presentations entry was removed from the list.SummaryDifference8%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.